Compound for inhibiting KRASG12C mutant protein, preparation method and application thereof
A compound, unsaturated technology, used in medical preparations containing active ingredients, organic chemistry, drug combinations, etc., can solve problems such as far unmet drug needs
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0103] Embodiment 1: the preparation of compound 1
[0104]
[0105] First prepare piperazine intermediate 1-5 according to the following route.
[0106]
[0107] Step 1: Synthesis of Intermediate 1-2
[0108] Compound 1-1 (4g, 18.5mmol) was dissolved in ethyl acetate (70ml), water (35ml), sodium bicarbonate solid (4.66g, 55.5mmol), benzyloxycarbonyl chloride (3.42ml, 24mmol) were added, Stir at room temperature for 2 hours. After the reaction, the organic phase was separated, washed with water (100ml*2), dried, concentrated, column chromatography (petroleum ether: ethyl acetate = 10:1 ~ 5:1) to obtain intermediate 1-2 (6.83g , colorless liquid).
[0109] Step 2: Synthesis of Intermediates 1-3
[0110] Compound 1-2 (6.83g, 19.5mmol), triethylamine (3.26ml, 23.4mmol) were dissolved in dichloromethane (60ml), p-toluenesulfonyl chloride (4.1g, 21.45mmol) was added dropwise, at room temperature Stir overnight. After the reaction was completed, it was concentrated and s...
PUM

Abstract
Description
Claims
Application Information

- Generate Ideas
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com